Moreover, the combination of radiotherapy and PD1/PDL1 inhibitors could induce the immune response of tumor antigen-specific T cells (CD8+ T cells), which enhanced the effector function of cytotoxic T lymphocyte (CTL) in tumor microenvironment to achieve more superior antitumor effect [42]. Here, PDCD1 is linked to neoplasm.